SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-003110
Filing Date
2024-03-13
Accepted
2024-03-13 16:16:56
Documents
17
Period of Report
2024-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20240313x8k.htm   iXBRL 8-K 39694
2 EX-99.1 chrs-20240313xex99d1.htm EX-99.1 321334
3 GRAPHIC chrs-20240313xex99d1001.jpg GRAPHIC 6713
  Complete submission text file 0001558370-24-003110.txt   521457

Data Files

Seq Description Document Type Size
4 EX-101.SCH chrs-20240313.xsd EX-101.SCH 4157
5 EX-101.DEF chrs-20240313_def.xml EX-101.DEF 3158
6 EX-101.LAB chrs-20240313_lab.xml EX-101.LAB 15907
7 EX-101.PRE chrs-20240313_pre.xml EX-101.PRE 10735
18 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20240313x8k_htm.xml XML 4903
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 24746125
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)